PATHways Program UK Healthcare

PATHways Program UK Healthcare

Services:
Payment/Insurance/Funding Accepted
• Cash or self-payment
• Private health insurance
• Federal, or any government funding for substance use treatment programs
• Medicare
• Federal military insurance (e.g., TRICARE)
• Medicaid

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Facility Operation (e.g., Private, Public)

• State government

Facility Vaping Policy

• Vaping permitted in designated area

Transitional Services

• Outcome follow-up after discharge
• Naloxone and overdose education
• Discharge Planning
• Aftercare/continuing care

Language Services

• Sign language services for the deaf and hard of hearing

Age Groups Accepted

• Adults

Gender Accepted

• Female

Ancillary Services

• Integrated primary care services
• Suicide prevention services
• Mental health services
• Early intervention for HIV
• Case management service

Assessment/Pre-treatment

• Screening for substance use
• Interim services for clients
• Professional interventionist/educational consultant
• Comprehensive substance use assessment
• Screening for mental disorders
• Complete medical history/physical exam
• Outreach to persons in the community
• Screening for tobacco use

Type of Opioid Treatment

• Buprenorphine maintenance
• Relapse prevention with naltrexone
• Prescribes naltrexone
• Prescribes buprenorphine
• Maintenance service with medically supervised withdrawal after stabilization

Recovery Support Services

• Housing services
• Assistance with obtaining social services
• Recovery coach
• Self-help groups
• Mentoring/peer support

Special Programs/Groups Offered

• Clients who have experienced sexual abuse
• Clients who have experienced trauma
• Clients with co-occurring mental and substance use disorders
• Clients with HIV or AIDS
• Pregnant/postpartum women
• Clients who have experienced intimate partner violence, domestic violence
• Veterans
• Criminal justice (other than DUI/DWI)/Forensic clients
• Clients with co-occurring pain and substance use disorders

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Regular outpatient treatment
• Outpatient
• Outpatient methadone/buprenorphine or naltrexone treatment

Pharmacotherapies

• Non-nicotine smoking/tobacco cessation
• Clonidine
• Medications for pre-exposure to prophylaxis
• Medications for HIV treatment
• Buprenorphine without naloxone
• Buprenorphine sub-dermal implant
• Naltrexone (oral)
• Buprenorphine with naloxone
• Medications for Hepatitis C treatment
• Nicotine replacement
• Medication for mental disorders
• Buprenorphine (extended-release, injectable)

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Hospitals

• General Hospital (including VA hospital)

Medical Services

• Hepatitis B (HBV) vaccination
• Hepatitis A (HAV) vaccination

License/Certification/Accreditation

• The Joint Commission

Education and Counseling Services

• HIV or AIDS education, counseling, or support
• Marital/couples counseling
• Hepatitis education, counseling, or support
• Group counseling
• Individual counseling
• Family counseling
• Health education services other than HIV/AIDS or hepatitis
• Smoking/vaping/tobacco cessation counseling
• Substance use disorder education

Facility Smoking Policy

• Smoking permitted in designated area

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Treatment Approaches

• Contingency management/motivational incentives
• Telemedicine/telehealth therapy
• Relapse prevention
• Trauma-related counseling
• Brief intervention
• Matrix Model
• Substance use disorder counseling
• 12-step facilitation
• Cognitive behavioral therapy
• Motivational interviewing

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Testing

• Metabolic syndrome monitoring
• Breathalyzer or blood alcohol testing
• Testing for Hepatitis B (HBV)
• Testing for Hepatitis C (HCV)
• STD testing
• TB screening
• Drug or alcohol urine screening
• HIV testing